Anyagértékelés - CoRAP
Anyagértékelés - CoRAP
Anyagértékelés - CoRAP
If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).
For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.
Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information. Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.
- Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
- The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
- When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
- When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
- Contact details of the evaluating Member States are provided for all the substance included.
- Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.
Legend:
Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio
Last updated 11 szeptember 2024. Database contains 402 unique substances/entries.
CASSIFFIX
|
422-040-1
|
426218-78-2
|
2016
|
Spain
|
Suspected PBT/vPvB Exposure of environment High RCR |
Concluded
|
Details |
WASOX-VMAC2
|
458-680-3
|
797751-44-1
|
2019
|
Spain
|
Suspected PBT/vPvB Exposure of environment |
Information requested
|
Details |
204-820-1
|
127-06-0
|
2016
|
Austria
|
Suspected Carcinogenic Suspected Mutagenic Suspected Sensitiser Exposure of environment Exposure of workers High RCR Wide dispersive use |
Concluded
|
Details | |
800-353-8
|
1379524-06-7
|
2016
|
Germany
|
Suspected PBT/vPvB Other hazard based concern Exposure of environment High RCR Wide dispersive use |
Concluded
|
Details | |
480-310-4
|
-
|
2017
|
Germany
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details | |
700-242-3
|
62037-80-3
|
2017
|
Germany
|
Suspected PBT/vPvB Exposure of environment |
Information requested
|
Details | |
700-323-3
|
908020-52-0
|
2017
|
Germany
|
Suspected PBT/vPvB Exposure of environment |
Concluded
|
Details | |
-
|
-
|
2018
|
Belgium
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details | |
270-128-1
|
68411-46-1
|
2016
|
Germany
|
Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
202-394-1
|
95-14-7
|
2016
|
Germany
|
Potential endocrine disruptor Exposure of environment |
Concluded
|
Details | |
421-450-8
|
154702-15-5
|
2015
|
Germany
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details | |
247-426-5
|
26040-51-7
|
2019
|
Sweden
|
Potential endocrine disruptor Suspected PBT/vPvB Other hazard based concern Exposure of environment Wide dispersive use |
Concluded
|
Details | |
203-372-4
|
106-20-7
|
2019
|
Portugal
|
Suspected PBT/vPvB Exposure of environment |
Ongoing
|
Details | |
700-183-3
|
52299-25-9
|
2018
|
Germany
|
Suspected PBT/vPvB Other hazard based concern Exposure of environment |
Concluded
|
Details | |
609-946-4
|
41637-38-1
|
Germany
|
Suspected PBT/vPvB Exposure of environment |
Withdrawn
|
Details | ||
245-366-4
|
22984-54-9
|
Italy
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
218-747-8
|
2224-33-1
|
Italy
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
203-629-0
|
108-91-8
|
2016
|
Belgium
|
Reprotoxic Exposure of environment High (aggregated) tonnage |
Concluded
|
Details | |
205-491-7
|
141-62-8
|
2015
|
Norway
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details | |
201-545-9
|
84-61-7
|
2017
|
Sweden
|
Potential endocrine disruptor Exposure of environment Wide dispersive use |
Concluded
|
Details | |
210-871-0
|
624-92-0
|
2014
|
Germany
|
Exposure of environment High (aggregated) tonnage Other exposure/risk based concern |
Concluded
|
Details | |
231-673-0
|
7681-57-4
|
2014
|
Hungary
|
Suspected CMR Exposure of environment Exposure of sensitive populations High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
205-492-2
|
141-63-9
|
2015
|
Norway
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details | |
404-740-9
|
115895-09-5
|
2016
|
Slovenia
|
Suspected PBT/vPvB Exposure of environment |
Information requested
|
Details | |
272-902-4
|
68919-76-6
|
Germany
|
Suspected PBT/vPvB Exposure of environment |
Withdrawn
|
Details | ||
701-057-0
|
-
|
Germany
|
Suspected PBT/vPvB Exposure of environment High RCR Wide dispersive use |
Withdrawn
|
Details | ||
931-745-8
|
-
|
2014
|
Sweden
|
Suspected PBT/vPvB Exposure of environment High RCR |
Conclusion under preparation
|
Details | |
249-535-3
|
29253-36-9
|
Austria
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
205-201-9
|
135-57-9
|
2014
|
Belgium
|
Suspected PBT/vPvB Exposure of environment |
Concluded
|
Details | |
629-767-5
|
1228186-18-2
|
Germany
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
220-260-0
|
2691-41-0
|
Hungary
|
Suspected Carcinogenic Suspected Reprotoxic Exposure of environment Exposure of workers Wide dispersive use |
Withdrawn
|
Details | ||
206-420-2
|
338-83-0
|
2020
|
Belgium
|
Suspected PBT/vPvB Exposure of environment |
Follow-up
|
Details | |
204-500-1
|
121-82-4
|
Hungary
|
Suspected Carcinogenic Suspected Reprotoxic Exposure of environment Exposure of workers Wide dispersive use |
Withdrawn
|
Details | ||
271-867-2
|
68610-51-5
|
2016
|
Spain
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Information requested
|
Details | |
468-710-7
|
754-12-1
|
2012
|
Germany
|
Other hazard based concern Exposure of environment High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
444-340-1
|
-
|
2017
|
Germany
|
Suspected PBT/vPvB Exposure of environment |
Concluded
|
Details | |
295-835-2
|
92129-33-4
|
2015
|
Italy
|
Exposure of environment High (aggregated) tonnage Other exposure/risk based concern Wide dispersive use |
Concluded
|
Details | |
264-120-7
|
63393-96-4
|
2017
|
Italy
|
Suspected PBT/vPvB Exposure of environment High RCR Wide dispersive use |
Concluded
|
Details | |
EC No. 415-490-5 and 604-250-7
show/hide
reaction mass of (1S,1'R)-2-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy]-2-methylpropyl propanoate, (1R,1'R)-2-[1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy]-2-methylpropyl propanoate and 2-methyl-2-{[(1R,2R)-2,6,6-trimethylcycloheptyl]oxy}propyl propanoate
EC / List no:
604-250-7
| CAS no:
141773-73-1
2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate
HELVETOLIDE
EC / List no:
415-490-5
| CAS no:
141773-73-1
|
-
|
-
|
2016
|
Germany
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details |
905-459-9
|
-
|
2025
|
France
|
Suspected Reprotoxic Suspected PBT/vPvB Other hazard based concern Exposure of environment Exposure of workers High (aggregated) tonnage |
Not started
|
Details | |
915-730-3
|
-
|
2017
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Exposure of environment High RCR Wide dispersive use |
Information requested
|
Details | |
473-390-7
|
-
|
2016
|
Belgium
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details | |
906-484-8
|
-
|
2015
|
Slovenia
|
Suspected PBT/vPvB Exposure of environment High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
430-050-2
|
-
|
2017
|
Spain
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details | |
939-505-4
|
-
|
2023
|
France
|
Potential endocrine disruptor Exposure of environment |
Ongoing
|
Details | |
X4261
|
401-850-9
|
255881-94-8
|
2014
|
Belgium
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Concluded
|
Details |
447-780-2
|
-
|
2014
|
Estonia
|
Suspected CMR Suspected PBT/vPvB Exposure of environment Exposure of workers |
Concluded
|
Details | |
203-929-1
|
112-03-8
|
Italy
|
Suspected PBT/vPvB Exposure of environment Wide dispersive use |
Withdrawn
|
Details | ||
246-677-8
|
25155-23-1
|
2014
|
Italy
|
Suspected PBT/vPvB Exposure of environment Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use |
Concluded
|
Details | |
204-881-4
|
128-37-0
|
2016
|
France
|
Potential endocrine disruptor Exposure of sensitive populations Exposure of workers High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
258-469-4
|
53306-54-0
|
2020
|
Germany
|
Potential endocrine disruptor Exposure of sensitive populations High (aggregated) tonnage Wide dispersive use |
Information requested
|
Details | |
629-732-4
|
1224966-13-5
|
2015
|
Lithuania
|
Sensitiser Exposure of sensitive populations Exposure of workers |
Concluded
|
Details | |
220-449-8
|
2768-02-7
|
2013
|
Sweden
|
Suspected Sensitiser Exposure of sensitive populations Exposure of workers High (aggregated) tonnage High RCR Wide dispersive use |
Concluded
|
Details | |
202-773-1
|
99-62-7
|
2025
|
France
|
Suspected Reprotoxic Suspected PBT/vPvB Exposure of workers |
Not started
|
Details | |
222-429-4
|
3468-63-1
|
2019
|
Germany
|
Suspected Carcinogenic Suspected Reprotoxic Suspected PBT/vPvB Exposure of workers Wide dispersive use |
Concluded
|
Details | |
249-820-2
|
29736-75-2
|
2018
|
Germany
|
Suspected Carcinogenic Suspected Reprotoxic Other hazard based concern Exposure of workers |
Follow-up
|
Details | |
239-701-3
|
15625-89-5
|
2014
|
France
|
Sensitiser Exposure of workers High RCR Wide dispersive use |
Concluded
|
Details | |
202-627-7
|
98-01-1
|
2022
|
Denmark
|
Suspected Carcinogenic Suspected Mutagenic Exposure of workers High (aggregated) tonnage Wide dispersive use |
Information requested
|
Details | |
221-975-0
|
3302-10-1
|
Spain
|
Suspected Reprotoxic Exposure of workers |
Withdrawn
|
Details | ||
203-680-9
|
109-55-7
|
2014
|
Austria
|
Sensitiser Exposure of workers High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
264-727-7
|
64194-22-5
|
Slovenia
|
Suspected Carcinogenic Exposure of workers Wide dispersive use |
Withdrawn
|
Details | ||
201-052-9
|
77-73-6
|
2016
|
France
|
Suspected Reprotoxic Exposure of workers High (aggregated) tonnage High RCR |
Concluded
|
Details | |
219-207-4
|
2386-87-0
|
2013
|
Ireland
|
Suspected CMR Sensitiser Exposure of workers High RCR |
Concluded
|
Details | |
247-118-0
|
25584-83-2
|
2025
|
France
|
Suspected Carcinogenic Suspected Mutagenic Suspected Sensitiser Exposure of workers High (aggregated) tonnage High RCR Other exposure/risk based concern Wide dispersive use |
Not started
|
Details | |
231-208-1
|
7446-70-0
|
2015
|
France
|
Suspected CMR Exposure of workers High (aggregated) tonnage High RCR |
Follow-up
|
Details | |
232-235-1
|
7790-98-9
|
2015
|
Germany
|
Suspected Carcinogenic Potential endocrine disruptor Other hazard based concern Exposure of workers High RCR Wide dispersive use |
Concluded
|
Details | |
231-146-5
|
7440-36-0
|
2018
|
Germany
|
Suspected Carcinogenic Exposure of workers High (aggregated) tonnage High RCR Other exposure/risk based concern Wide dispersive use |
Follow-up
|
Details | |
215-713-4
|
1345-04-6
|
2018
|
Germany
|
Suspected Carcinogenic Exposure of workers High RCR Other exposure/risk based concern Wide dispersive use |
Follow-up
|
Details | |
225-935-3
|
5160-02-1
|
2020
|
Germany
|
Suspected Carcinogenic Exposure of workers Wide dispersive use |
Concluded
|
Details | |
202-859-9
|
100-51-6
|
2016
|
Germany
|
Suspected Sensitiser Exposure of workers High RCR Wide dispersive use |
Concluded
|
Details | |
218-487-5
|
2162-74-5
|
2025
|
Italy
|
Suspected PBT/vPvB Exposure of workers Wide dispersive use |
Not started
|
Details | |
237-695-7
|
13927-71-4
|
2020
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Exposure of workers |
Suspended
|
Details | |
243-001-3
|
19372-44-2
|
2015
|
Germany
|
Sensitiser Other hazard based concern Exposure of workers High (aggregated) tonnage |
Concluded
|
Details | |
203-628-5
|
108-90-7
|
2023
|
Netherlands
|
Suspected Mutagenic Suspected Reprotoxic Potential endocrine disruptor Exposure of workers High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
203-631-1
|
108-94-1
|
2016
|
Poland
|
Suspected Carcinogenic Suspected Mutagenic Suspected Reprotoxic Exposure of workers High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
234-042-8
|
10508-09-5
|
2015
|
Italy
|
Suspected Carcinogenic Suspected Mutagenic Exposure of workers Wide dispersive use |
Concluded
|
Details | |
214-189-4
|
1112-39-6
|
Belgium
|
Reprotoxic Other hazard based concern Exposure of workers |
Withdrawn
|
Details | ||
234-126-4
|
10544-72-6
|
Latvia
|
Suspected Mutagenic Suspected Reprotoxic Exposure of workers High RCR |
Withdrawn
|
Details | ||
203-584-7
|
108-45-2
|
2018
|
Latvia
|
Suspected Reprotoxic Sensitiser Exposure of workers High (aggregated) tonnage |
Concluded
|
Details | |
201-202-3
|
79-39-0
|
2016
|
Sweden
|
Other hazard based concern Exposure of workers |
Concluded
|
Details | |
202-049-5
|
91-20-3
|
2016
|
United Kingdom
|
Exposure of workers High (aggregated) tonnage High RCR Other exposure/risk based concern |
Concluded
|
Details | |
947-768-1
|
-
|
2025
|
Netherlands
|
Suspected Mutagenic Other hazard based concern Exposure of workers Wide dispersive use |
Not started
|
Details | |
204-857-3
|
127-68-4
|
Ireland
|
Suspected Reprotoxic Exposure of workers High (aggregated) tonnage |
Withdrawn
|
Details | ||
231-836-6
|
7758-19-2
|
2019
|
Hungary
|
Suspected Mutagenic Suspected Reprotoxic Exposure of workers Wide dispersive use |
Concluded
|
Details | |
205-739-4
|
149-44-0
|
2026
|
Netherlands
|
Suspected Carcinogenic Suspected Mutagenic Suspected Reprotoxic Exposure of workers High (aggregated) tonnage Wide dispersive use |
Not started
|
Details | |
231-511-9
|
7601-89-0
|
2015
|
Germany
|
Suspected Carcinogenic Potential endocrine disruptor Other hazard based concern Exposure of workers Wide dispersive use |
Concluded
|
Details | |
284-366-9
|
84852-53-9
|
2012
|
Sweden
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Conclusion under preparation
|
Details | |
244-617-5
|
21850-44-2
|
2017
|
Germany
|
Potential endocrine disruptor Suspected PBT/vPvB High (aggregated) tonnage |
Concluded
|
Details | |
213-668-5
|
999-97-3
|
2014
|
Spain
|
High (aggregated) tonnage High RCR |
Concluded
|
Details | |
701-339-3
|
-
|
2014
|
Denmark
|
Suspected CMR High (aggregated) tonnage Other exposure/risk based concern |
Concluded
|
Details | |
700-989-5
|
-
|
2014
|
Denmark
|
Suspected CMR High (aggregated) tonnage Other exposure/risk based concern |
Concluded
|
Details | |
271-089-3
|
68515-47-9
|
2014
|
Denmark
|
Suspected CMR High (aggregated) tonnage Other exposure/risk based concern |
Concluded
|
Details | |
271-085-1
|
68515-43-5
|
2014
|
Denmark
|
Suspected CMR High (aggregated) tonnage Other exposure/risk based concern |
Concluded
|
Details | |
202-425-9
|
95-50-1
|
2013
|
Hungary
|
Suspected CMR High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
627-083-1
|
244235-47-0
|
2015
|
Spain
|
Suspected PBT/vPvB High (aggregated) tonnage |
Concluded
|
Details | |
EC No. 216-133-4 and EC No. 244-240-6
show/hide
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one
EC / List no:
244-240-6
| CAS no:
21145-77-7
1-(5,6,7,8-tetrahydro-3,5,5,6,8,8-hexamethyl-2-naphthyl)ethan-1-one
EC / List no:
216-133-4
| CAS no:
1506-02-1
|
-
|
-
|
2020
|
Germany
|
Potential endocrine disruptor High (aggregated) tonnage |
Follow-up
|
Details |
203-868-0
|
111-42-2
|
2012
|
Germany
|
Suspected CMR High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
203-312-7
|
105-59-9
|
2013
|
United Kingdom
|
Suspected CMR High (aggregated) tonnage High RCR Wide dispersive use |
Concluded
|
Details | |
BENZYL-2-NAPHTHYLETHER; BETA-NAPHTHYLBENZYLETHER (BON); BNE; BON; NIPAFAX BNE; SENSLON-50; ZO-1
|
405-490-3
|
613-62-7
|
2012
|
Czech Republic
|
Other hazard based concern High (aggregated) tonnage |
Concluded
|
Details |
205-483-3
|
141-43-5
|
2014
|
United Kingdom
|
Suspected Sensitiser High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
253-781-7
|
38103-06-9
|
2013
|
Germany
|
Suspected PBT/vPvB High (aggregated) tonnage |
Concluded
|
Details | |
1 - 4.5 moles propoxylated
|
500-097-4
|
37353-75-6
|
2013
|
Denmark
|
Suspected CMR High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details |
201-250-5
|
80-09-1
|
2014
|
Belgium
|
Suspected CMR Potential endocrine disruptor High (aggregated) tonnage |
Concluded
|
Details | |
202-679-0
|
98-54-4
|
2014
|
Germany
|
Potential endocrine disruptor High (aggregated) tonnage |
Concluded
|
Details | |
246-678-3
|
25155-25-3
|
2015
|
Netherlands
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Follow-up
|
Details | |
287-477-0
|
85535-85-9
|
2012
|
United Kingdom
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
215-477-2
|
1327-41-9
|
2015
|
France
|
Suspected CMR High (aggregated) tonnage |
Follow-up
|
Details | |
217-175-6
|
1762-95-4
|
2015
|
Czech Republic
|
Suspected CMR Potential endocrine disruptor High (aggregated) tonnage High RCR Wide dispersive use |
Concluded
|
Details | |
810-801-4
|
-
|
2015
|
Netherlands
|
Suspected CMR Suspected PBT/vPvB High (aggregated) tonnage |
Ongoing
|
Details | |
202-163-5
|
92-52-4
|
2013
|
Portugal
|
Suspected PBT/vPvB High (aggregated) tonnage |
Concluded
|
Details | |
201-247-9
|
80-07-9
|
2019
|
Austria
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
254-052-6
|
38640-62-9
|
2013
|
Sweden
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Conclusion under preparation
|
Details | |
205-480-7
|
141-32-2
|
2013
|
Sweden
|
Suspected CMR High (aggregated) tonnage Other exposure/risk based concern |
Concluded
|
Details | |
215-160-9
|
1308-38-9
|
2019
|
France
|
Suspected Reprotoxic Suspected Sensitiser High (aggregated) tonnage |
Concluded
|
Details | |
202-046-9
|
91-17-8
|
2012
|
Finland
|
Suspected PBT/vPvB High (aggregated) tonnage |
Ongoing
|
Details | |
203-956-9
|
112-30-1
|
2012
|
Italy
|
Other hazard based concern High (aggregated) tonnage Other exposure/risk based concern Wide dispersive use |
Concluded
|
Details | |
200-901-0
|
75-78-5
|
2014
|
Czech Republic
|
Suspected PBT/vPvB High (aggregated) tonnage |
Concluded
|
Details | |
247-660-8
|
26401-35-4
|
2013
|
Spain
|
Suspected PBT/vPvB High (aggregated) tonnage Other exposure/risk based concern Wide dispersive use |
Concluded
|
Details | |
248-948-6
|
28299-41-4
|
2014
|
Netherlands
|
Suspected PBT/vPvB High (aggregated) tonnage |
Information requested
|
Details | |
287-401-6
|
85507-79-5
|
2014
|
Denmark
|
Suspected CMR High (aggregated) tonnage Other exposure/risk based concern |
Concluded
|
Details | |
211-063-0
|
628-96-6
|
2016
|
Italy
|
Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB Suspected Sensitiser High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
931-274-8
|
-
|
2014
|
Slovenia
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
204-127-4
|
116-15-4
|
2015
|
Italy
|
Suspected CMR High (aggregated) tonnage |
Concluded
|
Details | |
250-610-8
|
31394-54-4
|
2012
|
Latvia
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
203-571-6
|
108-31-6
|
2013
|
Austria
|
Sensitiser High (aggregated) tonnage High RCR |
Concluded
|
Details | |
221-375-9
|
3081-14-9
|
2012
|
Belgium
|
Suspected PBT/vPvB High (aggregated) tonnage |
Concluded
|
Details | |
1 - 2.5 moles ethoxylated
|
500-209-1
|
68412-54-4
|
2016
|
United Kingdom
|
Potential endocrine disruptor Other hazard based concern High (aggregated) tonnage |
Concluded
|
Details |
228-250-8
|
6197-30-4
|
2012
|
France
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Information requested
|
Details | |
show/hide
|
700-960-7
|
-
|
2012
|
Denmark
|
Potential endocrine disruptor Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details |
907-745-9
|
-
|
2015
|
Belgium
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
701-385-4
|
-
|
2021
|
France
|
Suspected Mutagenic Suspected PBT/vPvB High (aggregated) tonnage |
Information requested
|
Details | |
203-585-2
|
108-46-3
|
2019
|
France
|
Potential endocrine disruptor High (aggregated) tonnage |
Information requested
|
Details | |
231-131-3
|
7440-22-4
|
2014
|
Netherlands
|
Other hazard based concern High (aggregated) tonnage Other exposure/risk based concern Wide dispersive use |
Concluded
|
Details | |
203-570-0
|
108-30-5
|
2013
|
Austria
|
Suspected CMR Sensitiser High (aggregated) tonnage High RCR |
Concluded
|
Details | |
216-653-1
|
1634-04-4
|
2014
|
France
|
Potential endocrine disruptor High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
205-286-2
|
137-26-8
|
2014
|
Sweden
|
Potential endocrine disruptor High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
222-182-2
|
3380-34-5
|
2012
|
Netherlands
|
Potential endocrine disruptor Suspected PBT/vPvB High (aggregated) tonnage |
Follow-up
|
Details | |
222-020-0
|
3319-31-1
|
2012
|
Austria
|
Suspected PBT/vPvB High (aggregated) tonnage Wide dispersive use |
Ongoing
|
Details | |
809-930-9
|
1330-78-5
|
2014
|
Netherlands
|
Suspected PBT/vPvB Other hazard based concern High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
231-944-3
|
7779-90-0
|
2013
|
Romania
|
High (aggregated) tonnage Wide dispersive use |
Concluded
|
Details | |
201-222-2
|
79-74-3
|
2014
|
Italy
|
Suspected PBT/vPvB High RCR |
Follow-up
|
Details | |
200-657-5
|
67-51-6
|
Spain
|
Reprotoxic High RCR |
Withdrawn
|
Details | ||
CIS/TRANS-TIMO; FLOROL; FLOROSA
|
405-040-6
|
63500-71-0
|
2012
|
Spain
|
High RCR Wide dispersive use |
Concluded
|
Details |
211-745-8
|
693-21-0
|
2016
|
Italy
|
Suspected Carcinogenic Suspected Reprotoxic Potential endocrine disruptor Suspected PBT/vPvB High RCR |
Concluded
|
Details | |
205-288-3
|
137-30-4
|
2012
|
Denmark
|
Potential endocrine disruptor High RCR |
Information requested
|
Details | |
218-645-3
|
2210-79-9
|
2016
|
Denmark
|
Mutagenic |
Concluded
|
Details | |
209-711-2
|
591-27-5
|
2020
|
Italy
|
Mutagenic Sensitiser Other hazard based concern |
Follow-up
|
Details | |
204-616-2
|
123-30-8
|
2020
|
Italy
|
Mutagenic Sensitiser Other hazard based concern |
Concluded
|
Details | |
220-618-6
|
2835-95-2
|
2020
|
Italy
|
Mutagenic Sensitiser Other hazard based concern |
Information requested
|
Details | |
200-237-1
|
55-55-0
|
2020
|
Italy
|
Mutagenic Sensitiser Other hazard based concern |
Concluded
|
Details | |
D-8; DD-8
|
405-520-5
|
95235-30-6
|
2025
|
Belgium
|
Potential endocrine disruptor Other exposure/risk based concern |
Not started
|
Details |
231-150-7
|
7440-41-7
|
2013
|
Germany
|
Other exposure/risk based concern |
Concluded
|
Details | |
206-354-4
|
330-54-1
|
2014
|
Finland
|
Potential endocrine disruptor Other exposure/risk based concern Wide dispersive use |
Concluded
|
Details | |
231-545-4
|
7631-86-9
|
2012
|
Netherlands
|
Other hazard based concern Other exposure/risk based concern |
Concluded
|
Details | |
931-292-6
|
308062-28-4
|
Ireland
|
Suspected Reprotoxic Other hazard based concern |
Withdrawn
|
Details | ||
429-320-2
|
24748-23-0
|
2019
|
Netherlands
|
PBT/vPvB |
Information requested
|
Details | |
701-394-3
|
1782069-81-1
|
2020
|
Germany
|
Potential endocrine disruptor |
Concluded
|
Details | |
229-962-1
|
6864-37-5
|
2015
|
Germany
|
Potential endocrine disruptor |
Concluded
|
Details | |
627-872-0
|
1514-82-5
|
2019
|
Spain
|
Suspected Reprotoxic Potential endocrine disruptor |
Concluded
|
Details | |
248-227-6
|
27107-89-7
|
Netherlands
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
204-263-4
|
118-60-5
|
Germany
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
201-240-0
|
79-97-0
|
2021
|
Germany
|
Suspected Reprotoxic Potential endocrine disruptor |
Information requested
|
Details | |
204-327-1
|
119-47-1
|
2016
|
Denmark
|
Suspected Reprotoxic Potential endocrine disruptor |
Concluded
|
Details | |
251-020-3
|
32388-55-9
|
Netherlands
|
Potential endocrine disruptor Suspected PBT/vPvB |
Withdrawn
|
Details | ||
204-262-9
|
118-58-1
|
Germany
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
201-248-4
|
80-08-0
|
2016
|
Germany
|
Potential endocrine disruptor |
Concluded
|
Details | |
278-355-8
|
75980-60-8
|
Sweden
|
Reprotoxic Potential endocrine disruptor |
Withdrawn
|
Details | ||
204-399-4
|
120-47-8
|
Germany
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
432-520-2
|
232938-43-1
|
Belgium
|
Suspected Reprotoxic Potential endocrine disruptor |
Withdrawn
|
Details | ||
310-154-3
|
121158-58-5
|
2018
|
Germany
|
Potential endocrine disruptor |
Concluded
|
Details | |
273-066-3
|
68937-41-7
|
2020
|
Netherlands
|
Potential endocrine disruptor Suspected PBT/vPvB |
Information requested
|
Details | |
219-006-1
|
2312-35-8
|
2019
|
Netherlands
|
Potential endocrine disruptor Suspected PBT/vPvB |
Concluded
|
Details | |
701-263-0
|
-
|
2020
|
Denmark
|
Potential endocrine disruptor |
Concluded
|
Details | |
202-924-1
|
101-20-2
|
2019
|
France
|
Suspected Reprotoxic Potential endocrine disruptor Wide dispersive use |
Concluded
|
Details | |
237-159-2
|
13674-87-8
|
Germany
|
Potential endocrine disruptor |
Withdrawn
|
Details | ||
203-253-7
|
104-93-8
|
2021
|
Ireland
|
Reprotoxic |
Concluded
|
Details | |
253-057-0
|
36483-57-5
|
Denmark
|
Suspected Carcinogenic Suspected Mutagenic |
Withdrawn
|
Details | ||
202-025-4
|
90-93-7
|
2021
|
Netherlands
|
Suspected Carcinogenic Suspected Mutagenic |
Concluded
|
Details | |
233-047-2
|
10025-91-9
|
2018
|
Germany
|
Suspected Carcinogenic Suspected Reprotoxic |
Concluded
|
Details | |
223-055-4
|
3710-84-7
|
2019
|
Sweden
|
Suspected Carcinogenic Suspected Mutagenic |
Concluded
|
Details | |
270-877-4
|
68479-98-1
|
2016
|
Denmark
|
Suspected Mutagenic Suspected Reprotoxic |
Concluded
|
Details | |
247-156-8
|
25640-78-2
|
Germany
|
Suspected PBT/vPvB Wide dispersive use |
Withdrawn
|
Details | ||
241-867-7
|
17928-28-8
|
Norway
|
Suspected PBT/vPvB Wide dispersive use |
Withdrawn
|
Details | ||
217-496-1
|
1873-88-7
|
Norway
|
Suspected PBT/vPvB |
Withdrawn
|
Details | ||
216-475-4
|
1594-08-7
|
2019
|
Belgium
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
226-866-1
|
5521-31-3
|
Belgium
|
Suspected PBT/vPvB |
Withdrawn
|
Details | ||
233-593-1
|
10254-57-6
|
Germany
|
Suspected PBT/vPvB |
Withdrawn
|
Details | ||
421-820-9
|
192268-65-8
|
2025
|
Netherlands
|
Suspected PBT/vPvB |
Not started
|
Details | |
309-912-6
|
101357-15-7
|
2019
|
Germany
|
Suspected PBT/vPvB |
Concluded
|
Details | |
229-782-3
|
6731-36-8
|
2014
|
Germany
|
Suspected PBT/vPvB |
Information requested
|
Details | |
205-117-2
|
133-66-4
|
Italy
|
Suspected PBT/vPvB Wide dispersive use |
Withdrawn
|
Details | ||
484-410-9
|
920979-28-8
|
2019
|
Spain
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
IRGANOX L 118
|
404-800-4
|
118832-72-7
|
2014
|
Germany
|
Suspected PBT/vPvB |
Concluded
|
Details |
221-374-3
|
3081-01-4
|
2012
|
Austria
|
Suspected PBT/vPvB Wide dispersive use |
Ongoing
|
Details | |
201-983-0
|
90-30-2
|
2012
|
Germany
|
Suspected PBT/vPvB Wide dispersive use |
Concluded
|
Details | |
267-636-0
|
67905-17-3
|
2019
|
Belgium
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
209-909-9
|
597-82-0
|
2016
|
Netherlands
|
Suspected PBT/vPvB |
Follow-up
|
Details | |
201-344-6
|
81-33-4
|
Belgium
|
Suspected PBT/vPvB |
Withdrawn
|
Details | ||
422-270-2
|
163702-08-7
|
2019
|
Spain
|
Suspected PBT/vPvB |
Ongoing
|
Details | |
700-161-3
|
-
|
2013
|
Netherlands
|
Suspected PBT/vPvB |
Ongoing
|
Details | |